MONTELEONE, IVAN SALVATORE
 Distribuzione geografica
Continente #
NA - Nord America 23.871
EU - Europa 1.934
AS - Asia 555
SA - Sud America 11
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
Totale 26.394
Nazione #
US - Stati Uniti d'America 23.856
DE - Germania 356
CN - Cina 327
UA - Ucraina 292
IT - Italia 268
IE - Irlanda 260
PL - Polonia 154
SE - Svezia 144
FR - Francia 137
GB - Regno Unito 100
SG - Singapore 89
KR - Corea 79
RU - Federazione Russa 78
FI - Finlandia 72
BE - Belgio 31
IN - India 14
JP - Giappone 10
NL - Olanda 9
CA - Canada 8
HK - Hong Kong 7
SC - Seychelles 7
KG - Kirghizistan 6
RO - Romania 6
AU - Australia 5
BR - Brasile 5
CZ - Repubblica Ceca 5
IR - Iran 5
MX - Messico 5
A1 - Anonimo 4
AT - Austria 4
CH - Svizzera 4
CL - Cile 4
GR - Grecia 4
MK - Macedonia 4
VN - Vietnam 4
BD - Bangladesh 3
IL - Israele 3
DK - Danimarca 2
DM - Dominica 2
ES - Italia 2
EU - Europa 2
PH - Filippine 2
TR - Turchia 2
AR - Argentina 1
BG - Bulgaria 1
BJ - Benin 1
BT - Bhutan 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PE - Perù 1
TN - Tunisia 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 26.394
Città #
Woodbridge 6.941
Houston 6.151
Wilmington 6.008
Fairfield 881
Ann Arbor 750
Chandler 520
Ashburn 415
Seattle 365
Cambridge 296
Jacksonville 256
Dublin 231
Medford 171
Dearborn 168
Kraków 154
Rome 153
Beijing 150
New York 94
Lawrence 81
Singapore 58
San Diego 52
Zhengzhou 50
Menlo Park 43
Colorado Springs 36
Moscow 33
Brussels 31
Mülheim 30
Shanghai 20
North Hollywood 17
London 16
Mountain View 16
Palo Alto 16
Boardman 15
Milan 15
Norwalk 15
Seoul 15
Redwood City 14
Hefei 13
Falls Church 11
University Park 10
Verona 10
Chicago 9
Helsinki 9
Kunming 9
Nanjing 9
Nürnberg 9
Engelhard 7
Guangzhou 7
Hanover 7
Mahé 7
Nuremberg 7
Saint Louis 7
Saint Petersburg 7
Hong Kong 6
San Francisco 6
Hebei 5
Lappeenranta 5
Nepi 5
Amsterdam 4
Brisbane 4
Buffalo 4
Council Bluffs 4
Creede 4
Fuzhou 4
Hangzhou 4
Indiana 4
Mexico City 4
Nanchang 4
San Mateo 4
Atlanta 3
Bangalore 3
Baotou 3
Bari 3
Brno 3
Changsha 3
Chengdu 3
Chennai 3
Detroit 3
Dong Ket 3
Los Angeles 3
Mcallen 3
Ottawa 3
Phoenix 3
Pune 3
Shenyang 3
São Paulo 3
Tokyo 3
Vienna 3
Adana 2
Cernusco sul Naviglio 2
Chongqing 2
Clearwater 2
Del Norte 2
Dhaka 2
Florence 2
Groningen 2
Holon 2
Jinan 2
Lausanne 2
Licata 2
Magdeburg 2
Totale 24.569
Nome #
A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction 480
2-Methoxy-5-Amino-N-Hydroxybenzamide Sensitizes Colon Cancer Cells to TRAIL-Induced Apoptosis by Regulating Death Receptor 5 and Survivin Expression 464
Regulation of the T helper cell type 1 transcription factor T-bet in coeliac disease mucosa 461
2-Methoxy-5-amino-N-hydroxybenzamide, a derivative of mesalamine, inhibits colon cancer cell growth through cyclo-oxygenase-2-dependent and -independent mechanisms 457
A functional role of flip in conferring resistance of Crohn's disease lamina propria lymphocytes to FAS-mediated apoptosis 448
Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut 442
Inhibiting Oxidative Phosphorylation In Vivo Restrains Th17 Effector Responses and Ameliorates Murine Colitis 438
Interleukin-34 sustains inflammatory pathways in the gut 432
Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract 431
A functional role for Smad7 in sustaining colon cancer cell growth and survival 430
3020insC mutation within the NOD2 gene in Crohn's disease: frequency and association with clinical pattern in an Italian population 425
TNF-α producing innate lymphoid cells (ILCs) are increased in active celiac disease and contribute to promote intestinal atrophy in mice 423
Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection 419
Characterization of IL-17A-producing cells in celiac disease mucosa 413
Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease 412
Silencing of SH-PTP2 defines a crucial role in the inactivation of epidermal growth factor receptor by 5-aminosalicylic acid in colon cancer cells 407
Aryl hydrocarbon receptor and colitis 404
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 404
Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection 403
Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis 403
Local immune activity in acute coronary syndrome: oxLDL abrogates LPS-tolerance in mononuclear cells isolated from culprit lesion 401
Erratum: A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction (Cell Reports (2016) 16(3) (731–743) (S2211124716307677) (10.1016/j.celrep.2016.06.027)) 398
Helicobacter pylori infection associates with a mucosal downregulation of Ghrelin, negative regulator of Th1-cell responses 396
Distinct profiles of effector cytokines mark the different phases of Crohn's disease 395
Smad7 knockdown restores aryl hydrocarbon receptor-mediated protective signals in the gut 395
Interleukin-34 induces Cc-chemokine ligand 20 in gut epithelial cells 388
Serum regenerating islet-derived 3-alpha is a biomarker of mucosal enteropathies 387
Celiac disease-related inflammation is marked by reduction of Nkp44/Nkp46-double positive natural killer cells 385
Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophages 381
Involvement of interleukin-21 in the regulation of colitis-associated colon cancer 380
Inhibition of Smad7 With a Specific Antisense Oligonucleotide Facilitates TGF-β1-Mediated Suppression of Colitis 378
The aryl hydrocarbon receptor in inflammatory bowel disease: linking the environment to disease pathogenesis 378
Cytoskeletal proteins and resident flora 378
CARD15 mutation analysis in an Italian population: Leu1007fsinsC but neither Arg702Trp nor Gly908Arg mutations are associated with Crohn's disease 376
Regulation of the T helper cell type 1 transcription factor T-bet in coeliac disease mucosa 375
null 374
Tissue Inhibitor of Metalloproteinase-3 Regulates Inflammation in Human and Mouse Intestine. 374
CCL20 Is Negatively Regulated by TGF-β1 in Intestinal Epithelial Cells and Reduced in Crohn's Disease Patients With a Successful Response to Mongersen, a Smad7 Antisense Oligonucleotide 374
A Functional Role of Flip in Conferring Resistance of Crohn’s Disease Lamina Propria Lymphocytes to FAS-Mediated Apoptosis 371
A failure of transforming growth factor-beta1 negative regulation maintains sustained NF-kappaB activation in gut inflammation 367
Enhanced expression of the Fas pathway inhibitor, Flip, in the mucosa of patients with Crohn's disease 366
Th17-related cytokines in inflammatory bowel diseases: friends or foes? 366
Aryl hydrocarbon receptor-driven signals inhibit collagen synthesis in the gut 363
Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease 359
IL-25 prevents and cures fulminant hepatitis in mice through a myeloid-derived suppressor cell-dependent mechanism 355
Defective expression of scavenger receptors in celiac disease mucosa 354
IL-15 positively regulates IL-21 production in celiac disease mucosa 349
Th17-related cytokines: new players in the control of chronic intestinal inflammation 344
Phase I clinical trial of Smad7 knockdown using antisense oligonucleotide in patients with active Crohn's disease 344
Metastatic Crohn's disease of the forehead 335
Interleukin-21 enhances T-helper cell type 1 signaling and interferon-gamma production in Crohn's disease 334
Th17-cytokine blockers as a new approach for treating inflammatory bowel disease 333
Smad7 positively regulates keratinocyte proliferation in psoriasis 322
Interleukin-23 and Th17 cells in the control of gut inflammation 319
Regulation of homeostasis and inflammation in the intestine 318
Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease 314
Plasma cells in the mucosa of patients with inflammatory bowel disease produce granzyme B and possess cytotoxic activities 308
Impairment of ghrelin synthesis in Helicobacter pylori-colonized stomach: new clues for the pathogenesis of H. pylori-related gastric inflammation 303
Plasma cells in the mucosa of patients with inflammatory bowel disease produce granzyme B and possess cytotoxic activities 303
A functional role for Smad7 in sustaining colon cancer cell growth and survival 302
TNF-α producing innate lymphoid cells (ILCs) are increased in active celiac disease and contribute to promote intestinal atrophy in mice 301
The Food Additive Maltodextrin Promotes Endoplasmic Reticulum Stress–Driven Mucus Depletion and Exacerbates Intestinal Inflammation 296
Interleukin-34 sustains inflammatory pathways in the gut 294
Sodium chloride-enriched Diet Enhanced Inflammatory Cytokine Production and Exacerbated Experimental Colitis in Mice 289
A functional role for Smad7 in sustaining colon cancer cell growth and survival 286
Involvement of interleukin-15 and interleukin-21, two gamma-chain-related cytokines, in celiac disease 284
Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases 261
Induction of endoplasmic reticulum stress and inhibition of colon carcinogenesis by the anti-helmintic drug rafoxanide 182
Cadherin-11 is a Regulator of Intestinal Fibrosis 181
Progranulin sustains STAT3 hyper-activation and oncogenic function in colorectal cancer cells 166
NPD-0414-2 and NPD-0414-24, two chemical entities designed as aryl hydrocarbon receptor (AHR) ligands, inhibit gut inflammatory signals 153
Effect of chemical modulation of toll-like receptor 4 in an animal model of ulcerative colitis 152
Neutrophil extracellulartraps sustain inflammatory signals in ulcerative colitis 142
Metformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activation 119
Rafoxanide Induces Immunogenic Death of Colorectal Cancer Cells 108
null 78
The fragile X mental retardation protein regulates RIP1K and colorectal cancer resistance to necroptosis 72
Cadherin-11 Is a Regulator of Intestinal Fibrosis 68
NPD-0414-2 and NPD-0414-24, Two Chemical Entities Designed as Aryl Hydrocarbon Receptor (AhR) Ligands, Inhibit Gut Inflammatory Signals 60
The Fragile X Mental Retardation Protein Regulates RIPK1 and Colorectal Cancer Resistance to Necroptosis 42
GATA6 Deficiency Leads to Epithelial Barrier Dysfunction and Enhances Susceptibility to Gut Inflammation 38
Rafoxanide sensitizes colorectal cancer cells to TRAIL-mediated apoptosis 36
A pharmacological batch of Mongersen that downregulates Smad7 is effective as induction therapy in active Crohn's disease: a phase II, open-label study 34
Characterization of a novel IDH2‐R159H mutation in acute myeloid leukaemia: Effects on cell metabolism and differentiation 32
A Novel Smad7 Genetic Variant Mapping on the Genomic Region Targeted by Mongersen Is Associated with Crohn's Disease 29
The Deubiquitinating Enzyme OTUD5 Sustains Inflammatory Cytokine Response in Inflammatory Bowel Disease 28
An essential role of adenosine deaminase acting on RNA 1 in coeliac disease mucosa 25
A novel tumour enhancer function of Insulin-like growth factor II mRNA-binding protein 3 in colorectal cancer 22
Smad7 Sustains Stat3 Expression and Signaling in Colon Cancer Cells 19
Insulin-like Growth Factor II mRNA-Binding Protein 1 Regulates Pancreatic Cancer Cell Growth through the Surveillance of CDC25A mRNA 11
Niclosamide enema for active distal ulcerative colitis: a phase I, open-label study 11
Hepcidin Upregulation in Colorectal Cancer Associates with Accumulation of Regulatory Macrophages and Epithelial–Mesenchymal Transition and Correlates with Progression of the Disease 9
Totale 26.766
Categoria #
all - tutte 51.325
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.325


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.203 572 573 440 682 561 834 697 638 678 609 429 490
2020/20214.584 431 508 627 563 400 497 557 464 117 204 157 59
2021/2022907 38 87 54 25 31 98 50 35 88 93 89 219
2022/20231.283 101 132 15 177 124 264 94 89 103 84 82 18
2023/2024482 55 21 18 17 53 103 25 63 7 4 17 99
2024/202590 90 0 0 0 0 0 0 0 0 0 0 0
Totale 26.766